Detalhe da pesquisa
1.
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers.
Immunity
; 56(12): 2816-2835.e13, 2023 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38091953
2.
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αß+ T cells targeting multiple myeloma.
Blood
; 143(10): 895-911, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37890146
3.
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 119(25): e2122379119, 2022 06 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35696582
4.
Profiling of Natural Killer Interactions With Cancer Cells Using Mass Cytometry.
Lab Invest
; 103(8): 100174, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37169083
5.
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood
; 138(3): 273-282, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34292325
6.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33657221
7.
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Haematologica
; 107(11): 2617-2629, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35484649
8.
Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis.
Br J Haematol
; 195(3): 429-432, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34254289
9.
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Br J Haematol
; 194(1): 145-157, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34124796
10.
The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(1): 123-131, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31563575
11.
Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations.
Biol Blood Marrow Transplant
; 26(4): 672-682, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31676338
12.
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(3): 529-539, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31678537
13.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant
; 26(10): 1930-1936, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32649981
14.
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Blood
; 131(23): 2515-2527, 2018 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29463563
15.
Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
Haematologica
; 105(2): 407-413, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31101756
16.
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 105(1): 47-58, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31537691
17.
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective study.
Transpl Int
; 33(9): 1089-1098, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32468720
18.
Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: A retrospective cohort study.
J Am Acad Dermatol
; 83(6): 1654-1658, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31689447
19.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1859-1868, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31132455
20.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
N Engl J Med
; 375(21): 2023-2036, 2016 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-27959731